|
U.S. Senator Sherrod Brown (D-Ohio) has asked the Food and Drug Administration (FDA) for a probe into outsourcing of pharmaceutical production, as well as ways to make drugmakers accountable for outsourced products that fail to meet quality standards. Following instances of contaminated heparin products from abroad, one FDA official charged during Congressional testimony that American drug companies are outsourcing operations to take advantage of weak drug safety standards abroad. Are new regulations really needed?
The preceding article is a "sneak peek" from Quality Control, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Quality Control today.
| 
